PHGUF Message Board Post 9822028 | Pharming Group Nv Ord
home / stock / phguf / phguf message board
laurenP
(investorshub)
Posted on: Mar/10/2018 12:13:17
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139187953
Roth Capital Reiterates Buy Rating For Pharming Group.
News, Short Squeeze, Breakout and More Instantly...
Pharming Group Nv Ord Company Name:
PHGUF Stock Symbol:
Market:
-
First quarter 2024 revenues increased by 31% to US$55.6 million, compared to the first quarter 2023, driven by the U.S. commercial launch of Joenja® and revenue growth of RUCONEST® RUCONEST® revenues increased by 8% to US$46.0 million, compared to the first quarte...
-
Recognition given for achievement in commercializing Joenja® (leniolisib), a first-in-class medication brought to market 10 years after disease state, APDS, was first characterized Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming” or “...
-
This multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency Leiden, the Netherlands, April 8, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHAR...